+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Cardiovascular Drugs Market Research Reports

Vasculitis - Pipeline Insight, 2024 - Product Thumbnail Image

Vasculitis - Pipeline Insight, 2024

  • Clinical Trials
  • February 2024
  • 80 Pages
  • Global
From
Potassium channel antagonists - Pipeline Insight, 2024 - Product Thumbnail Image

Potassium channel antagonists - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
Complement C1 inhibitors - Pipeline Insight, 2024 - Product Thumbnail Image

Complement C1 inhibitors - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
From
Purinoceptor P2Y12 antagonists - Pipeline Insight, 2024 - Product Thumbnail Image

Purinoceptor P2Y12 antagonists - Pipeline Insight, 2024

  • Drug Pipelines
  • January 2024
  • 60 Pages
  • Global
From
Apolipoprotein C-III inhibitors - Pipeline Insight, 2024 - Product Thumbnail Image

Apolipoprotein C-III inhibitors - Pipeline Insight, 2024

  • Drug Pipelines
  • January 2024
  • 60 Pages
  • Global
From
From
ACE/ARB Inhibitors - Pipeline Insight, 2024 - Product Thumbnail Image

ACE/ARB Inhibitors - Pipeline Insight, 2024

  • Drug Pipelines
  • January 2024
  • 60 Pages
  • Global
From
Angiotensin type 1 receptor antagonists - Pipeline Insight, 2024 - Product Thumbnail Image

Angiotensin type 1 receptor antagonists - Pipeline Insight, 2024

  • Drug Pipelines
  • January 2024
  • 60 Pages
  • Global
From
Alpha 1 adrenergic receptor antagonist - Pipeline Insight, 2024 - Product Thumbnail Image

Alpha 1 adrenergic receptor antagonist - Pipeline Insight, 2024

  • Drug Pipelines
  • January 2024
  • 60 Pages
  • Global
From
Sodium-glucose transporter 2 inhibitors - Pipeline Insight, 2024 - Product Thumbnail Image

Sodium-glucose transporter 2 inhibitors - Pipeline Insight, 2024

  • Drug Pipelines
  • January 2024
  • 60 Pages
  • Global
From
Matrix Metalloproteinase (MMP) Inhibitor - Pipeline Insight, 2024 - Product Thumbnail Image

Matrix Metalloproteinase (MMP) Inhibitor - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 120 Pages
  • Global
From
Adrenergic uptake inhibitors - Pipeline Insight, 2024 - Product Thumbnail Image

Adrenergic uptake inhibitors - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
Adrenergic Antagonist - Pipeline Insight, 2024 - Product Thumbnail Image

Adrenergic Antagonist - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 120 Pages
  • Global
From
Beta Receptor Agonist - Pipeline Insight, 2024 - Product Thumbnail Image

Beta Receptor Agonist - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 120 Pages
  • Global
From
Beta-1 Receptors Antagonist - Pipeline Insight, 2024 - Product Thumbnail Image

Beta-1 Receptors Antagonist - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
From
Kv1.3/1.5 Potassium Channel Blockers - Pipeline Insight, 2024 - Product Thumbnail Image

Kv1.3/1.5 Potassium Channel Blockers - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
Cholesterylester Transfer Protein (CETP) Inhibitor - Pipeline Insight, 2024 - Product Thumbnail Image

Cholesterylester Transfer Protein (CETP) Inhibitor - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 90 Pages
  • Global
From
Angiotensin Modulators - Pipeline Insight, 2024 - Product Thumbnail Image

Angiotensin Modulators - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
Loading Indicator

The Cardiovascular Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat cardiovascular diseases. These drugs are used to treat conditions such as hypertension, coronary artery disease, congestive heart failure, and arrhythmias. Cardiovascular drugs are also used to reduce the risk of stroke, heart attack, and other cardiovascular events. The market is composed of a variety of companies, ranging from large multinationals to small start-ups. Major players in the market include Pfizer, Merck, Novartis, Sanofi, and Bristol-Myers Squibb. These companies are involved in the research, development, and production of cardiovascular drugs. Additionally, there are a number of smaller companies that specialize in the production of generic cardiovascular drugs. These companies include Teva Pharmaceuticals, Mylan, and Sun Pharmaceuticals. Show Less Read more